amphetamine has been researched along with nafadotride in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Geracioti, TD; Logue, AD; Perdiue, J; Richtand, NM; Sethuraman, G; Spitzer, RH; Tubbs, LJ; Welge, JA | 1 |
| Barik, S; de Beaurepaire, R | 1 |
| Banasikowski, TJ; Beninger, RJ; MacLeod, LS | 1 |
3 other study(ies) available for amphetamine and nafadotride
| Article | Year |
|---|---|
The dopamine D3 receptor antagonist nafadotride inhibits development of locomotor sensitization to amphetamine.
Topics: Amphetamine; Animals; Behavior, Animal; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dopamine Uptake Inhibitors; Locomotion; Male; Naphthalenes; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D3; Tetrahydronaphthalenes | 2000 |
Dopamine D3 modulation of locomotor activity and sleep in the nucleus accumbens and in lobules 9 and 10 of the cerebellum in the rat.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amisulpride; Amphetamine; Animals; Cerebellum; Dopamine Agonists; Dopamine Antagonists; Dopamine Uptake Inhibitors; Female; Haloperidol; Microinjections; Motor Activity; Naphthalenes; Nucleus Accumbens; Pyrrolidines; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Dopamine D3; Sleep; Sulpiride; Tetrahydronaphthalenes | 2005 |
Comparison of nafadotride, CNQX, and haloperidol on acquisition versus expression of amphetamine-conditioned place preference in rats.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Amphetamine; Animals; Conditioning, Psychological; Haloperidol; Male; Naphthalenes; Pyrrolidines; Rats; Rats, Wistar; Receptors, AMPA; Receptors, Dopamine D2; Receptors, Dopamine D3 | 2012 |